Pembrolizumab

Keytruda

Near Add Your Location

Accepting patients

Pembrolizumab, Decitabine +/- Venetoclax

Phase 1b Study of Pembrolizumab, Decitabine +/- Venetoclax Combination Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Learn more
  • BCL-2 Inhibitor
  • Hypomethylating Agents (HMA)
  • Monoclonal Antibody
  • Phase 1